Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Classification of endometrial carcinoma: more than two types
Rajmohan Murali, Robert A. Soslow, Britta Weigelt
The Lancet Oncology (2014) Vol. 15, Iss. 7, pp. e268-e278
Closed Access | Times Cited: 581

Showing 1-25 of 581 citing articles:

Endometrial cancer
Philippe Morice, Alexandra Léary, Carien L. Creutzberg, et al.
The Lancet (2015) Vol. 387, Iss. 10023, pp. 1094-1108
Closed Access | Times Cited: 1361
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
Aline Talhouk, Melissa K. McConechy, Samuel Leung, et al.
Cancer (2017) Vol. 123, Iss. 5, pp. 802-813
Open Access | Times Cited: 781
A clinically applicable molecular-based classification for endometrial cancers
Aline Talhouk, Melissa K. McConechy, Samuel Leung, et al.
British Journal of Cancer (2015) Vol. 113, Iss. 2, pp. 299-310
Open Access | Times Cited: 778
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 16, pp. 4215-4224
Open Access | Times Cited: 693
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
Stefan Kommoss, Melissa K. McConechy, F. Kommoss, et al.
Annals of Oncology (2018) Vol. 29, Iss. 5, pp. 1180-1188
Open Access | Times Cited: 581
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Ellen Stelloo, Tjalling Bosse, Remi A. Nout, et al.
Modern Pathology (2015) Vol. 28, Iss. 6, pp. 836-844
Open Access | Times Cited: 400
Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening
Matteo Boretto, Nina Maenhoudt, Xinlong Luo, et al.
Nature Cell Biology (2019) Vol. 21, Iss. 8, pp. 1041-1051
Closed Access | Times Cited: 385
Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
David N. Church, Ellen Stelloo, Remi A. Nout, et al.
JNCI Journal of the National Cancer Institute (2014) Vol. 107, Iss. 1
Open Access | Times Cited: 296
New concepts for an old problem: the diagnosis of endometrial hyperplasia
Peter Sanderson, Hilary Critchley, Alistair Williams, et al.
Human Reproduction Update (2016)
Open Access | Times Cited: 290
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
Inge C. van Gool, Florine A. Eggink, Luke Freeman-Mills, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 14, pp. 3347-3355
Open Access | Times Cited: 269
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations
Yaser Hussein, Britta Weigelt, Douglas A. Levine, et al.
Modern Pathology (2014) Vol. 28, Iss. 4, pp. 505-514
Open Access | Times Cited: 201
The genetic landscape of endometrial clear cell carcinomas
Deborah F. DeLair, Kathleen A. Burke, Pier Selenica, et al.
The Journal of Pathology (2017) Vol. 243, Iss. 2, pp. 230-241
Open Access | Times Cited: 198
Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
Aline Talhouk, Lien Hoang, Melissa K. McConechy, et al.
Gynecologic Oncology (2016) Vol. 143, Iss. 1, pp. 46-53
Open Access | Times Cited: 188
New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care
Aline Talhouk, Jessica N. McAlpine
Gynecologic Oncology Research and Practice (2016) Vol. 3, Iss. 1
Open Access | Times Cited: 188
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
Melissa K. McConechy, Aline Talhouk, Samuel Leung, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 12, pp. 2865-2873
Open Access | Times Cited: 170
The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions
Matthias Alexa, Annette Hasenburg, Marco Johannes Battista
Cancers (2021) Vol. 13, Iss. 6, pp. 1478-1478
Open Access | Times Cited: 138
New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines
Angela Santoro, Giuseppe Angelico, Antonio Travaglino, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2623-2623
Open Access | Times Cited: 133
Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives
Ilaria Cuccu, Ottavia D’Oria, Ludovica Sgamba, et al.
Healthcare (2023) Vol. 11, Iss. 4, pp. 571-571
Open Access | Times Cited: 55
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
Eric Rios‐Doria, Amir Momeni Boroujeni, Claire F. Friedman, et al.
Gynecologic Oncology (2023) Vol. 174, pp. 262-272
Open Access | Times Cited: 46
FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy
Na Zhang, Yang Meng, Song Mao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Endometrial cancer: Not your grandmother's cancer
Jessica N. McAlpine, Sarah M. Temkin, Helen Mackay
Cancer (2016) Vol. 122, Iss. 18, pp. 2787-2798
Open Access | Times Cited: 164
Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis
Adrían V. Hernández, Vinay Pasupuleti, Vicente A. Benítes-Zapata, et al.
European Journal of Cancer (2015) Vol. 51, Iss. 18, pp. 2747-2758
Open Access | Times Cited: 141
Bokhman Redux: Endometrial cancer “types” in the 21st century
Adrian A. Suarez, Ashley S. Felix, David E. Cohn
Gynecologic Oncology (2016) Vol. 144, Iss. 2, pp. 243-249
Closed Access | Times Cited: 139
Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER–Medicare Linked Database
Britton Trabert, Nicolas Wentzensen, Ashley S. Felix, et al.
Cancer Epidemiology Biomarkers & Prevention (2015) Vol. 24, Iss. 1, pp. 261-267
Open Access | Times Cited: 136
Estrogen receptor β: the guardian of the endometrium
D Hapangama, Areege Mustafa Kamal, J. N. Bulmer
Human Reproduction Update (2014) Vol. 21, Iss. 2, pp. 174-193
Open Access | Times Cited: 126
Page 1 - Next Page

Scroll to top